For the quarter ending 2025-09-30, ARX had $227,000K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net (loss) income | -1,367,000 | 20,900 |
| Profits interest distribution expenses | 1,379,700 | - |
| Net realized gains on investments | 3,500 | 2,700 |
| Net unrealized gains on investments | 36,000 | 1,200 |
| Earnings from equity method investments | 300 | 1,200 |
| Share-based compensation expenses | 17,200 | 5,400 |
| Depreciation and amortization | 10,000 | 15,700 |
| Deferred income tax benefit | -1,100 | -10,700 |
| Net foreign exchange losses | 2,400 | -17,300 |
| Net accretion of discount on fixed maturity securities and short-term investments | 2,000 | 3,900 |
| Other, net | -2,400 | -400 |
| Premiums receivable | -10,000 | 112,700 |
| Ceded unearned premiums | -44,500 | 325,100 |
| Reinsurance recoverables on unpaid losses and lae | 133,400 | 327,100 |
| Other reinsurance recoverables | 40,100 | 112,700 |
| Deferred acquisition costs | 7,900 | -9,800 |
| Unpaid losses and loss adjustment expenses | 162,400 | 321,200 |
| Unearned premiums | 9,200 | 282,900 |
| Payables to reinsurers | -166,800 | 253,100 |
| Deferred ceding commissions | -10,800 | 59,500 |
| Funds held under reinsurance | -152,200 | -230,900 |
| Insurance balances payable | 42,600 | -19,200 |
| Other assets, accounts payable and other liabilities | -15,000 | -8,700 |
| Net cash provided by operating activities | 73,900 | 309,300 |
| Equity securities | 0 | 0 |
| Fixed maturity securities | 70,000 | 80,800 |
| Equity method investments | 1,100 | - |
| Other investments | 3,600 | - |
| Maturities of fixed maturity securities | 11,100 | 28,900 |
| Fixed maturity securities | 135,000 | 262,900 |
| Equity method investments | 400 | 400 |
| Net change in short-term investments | -15,100 | 10,200 |
| Purchases of subsidiaries, net of cash acquired | 8,500 | 1,400 |
| Capitalized technology development expenditures | 12,500 | 17,300 |
| Other, net | 0 | 300 |
| Net cash used in investing activities | -55,500 | -182,800 |
| Redemption of class c convertible preference shares | 175,300 | - |
| Issuance of common shares, net of issuance costs | 392,000 | - |
| Credit facility borrowings | 0 | 5,000 |
| Credit facility repayment | 5,000 | 0 |
| Issuance of debt, net of issuance costs | 0 | - |
| Payment of debt | 0 | - |
| Dividends paid to non-controlling interests | 3,100 | 4,100 |
| Net cash provided by (used in) financing activities | 208,600 | 900 |
| Net increase in cash, cash equivalents and restricted cash | 227,000 | 127,400 |
| Effect of exchange rate changes on cash | 48,500 | - |
| Cash and cash equivalents at beginning of period | 1,273,000 | - |
| Cash and cash equivalents at end of period | 1,675,900 | - |
Accelerant Holdings (ARX)
Accelerant Holdings (ARX)